Frontier Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.86M | Sell |
|
|||||
|
2025
Q1 | $10.7M | Sell |
|
|||||
|
2024
Q4 | $13.5M | Sell |
|
|||||
|
2024
Q3 | $14.4M | Sell |
|
|||||
|
2024
Q2 | $15.4M | Buy |
|
|||||
|
2024
Q1 | $18.5M | Buy |
|
|||||
|
2023
Q4 | $12.1M | Buy |
|
|||||
|
2023
Q3 | $9.29M | Buy |
|
|||||
|
2023
Q2 | $5.75M | Sell |
|
|||||
|
2023
Q1 | $5.57M | Sell |
|
|||||
|
2022
Q4 | $6.56M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $19K | Sell |
|
|||||
|
2013
Q4 | $47.3M | Buy |
|
|||||
|
2013
Q3 | $39.3M | Buy |
|
|||||
|
2013
Q2 | $29.9M | Buy |
|